These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9875391)

  • 1. Potent beta-lactam inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Grand-Maître C; Guse I; Haché B; Kawai S; Naud J; O'Meara JA; Plante R; Déziel R
    Antivir Chem Chemother; 1998 Sep; 9(5):379-87. PubMed ID: 9875391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Guse I; Haché B; Naud J; O'Meara JA; Plante R; Déziel R
    J Med Chem; 1998 Jul; 41(15):2882-91. PubMed ID: 9667976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of translactam HCMV protease inhibitors as potent antivirals.
    Borthwick AD
    Med Res Rev; 2005 Jul; 25(4):427-52. PubMed ID: 15789440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiviral activity of monobactams inhibiting the human cytomegalovirus protease.
    Ogilvie WW; Yoakim C; Dô F; Haché B; Lagacé L; Naud J; O'Meara JA; Déziel R
    Bioorg Med Chem; 1999 Aug; 7(8):1521-31. PubMed ID: 10482444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
    Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
    J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From 1-acyl-beta-lactam human cytomegalovirus protease inhibitors to 1-benzyloxycarbonylazetidines with improved antiviral activity. A straightforward approach to convert covalent to noncovalent inhibitors.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; De Clercq E; Balzarini J; González-Muñiz R
    J Med Chem; 2005 Apr; 48(7):2612-21. PubMed ID: 15801851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human cytomegalovirus proteinase by salcomine derivatives.
    Watanabe S; Konno K; Shigeta S; Yokota T
    Antivir Chem Chemother; 1998 May; 9(3):269-74. PubMed ID: 9875406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis of azapeptidomimetic beta-lactam molecules as potential protease inhibitors.
    Malachowski WP; Tie C; Wang K; Broadrup RL
    J Org Chem; 2002 Dec; 67(25):8962-9. PubMed ID: 12467415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease.
    Alexandre FR; Brandt G; Caillet C; Chaves D; Convard T; Derock M; Gloux D; Griffon Y; Lallos L; Leroy F; Liuzzi M; Loi AG; Moulat L; Musiu C; Parsy C; Rahali H; Roques V; Seifer M; Standring D; Surleraux D
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3984-91. PubMed ID: 26231161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidomimetic inhibitors of the human cytomegalovirus protease.
    Ogilvie W; Bailey M; Poupart MA; Abraham A; Bhavsar A; Bonneau P; Bordeleau J; Bousquet Y; Chabot C; Duceppe JS; Fazal G; Goulet S; Grand-Maître C; Guse I; Halmos T; Lavallée P; Leach M; Malenfant E; O'Meara J; Plante R; Plouffe C; Poirier M; Soucy F; Yoakim C; Déziel R
    J Med Chem; 1997 Dec; 40(25):4113-35. PubMed ID: 9406601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient and highly stereoselective synthesis of a beta-lactam inhibitor of the serine protease prostate-specific antigen.
    Annunziata R; Benaglia M; Cinquini M; Cozzi F; Puglisi A
    Bioorg Med Chem; 2002 Jun; 10(6):1813-8. PubMed ID: 11937339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxo-hexahydro-pyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 1. The alpha-methyl-trans-lactam template.
    Borthwick AD; Angier SJ; Crame AJ; Exall AM; Haley TM; Hart GJ; Mason AM; Pennell AM; Weingarten GG
    J Med Chem; 2000 Nov; 43(23):4452-64. PubMed ID: 11087570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective nonpeptidic inhibitors of herpes simplex virus type 1 and human cytomegalovirus proteases.
    Matsumoto M; Misawa S; Chiba N; Takaku H; Hayashi H
    Biol Pharm Bull; 2001 Mar; 24(3):236-41. PubMed ID: 11256477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient synthesis of an enantiopure beta-lactam as an advanced precursor of thrombin and tryptase inhibitors.
    Annunziata R; Benaglia M; Cinquini M; Cozzi F; Maggioni F; Puglisi A
    J Org Chem; 2003 Apr; 68(7):2952-5. PubMed ID: 12662075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-HCMV activity of 1-acyl-beta-lactams and 1-acylazetidines derived from phenylalanine.
    Gerona-Navarro G; Pérez de Vega MJ; García-López MT; Andrei G; Snoeck R; Balzarini J; De Clercq E; González-Muñiz R
    Bioorg Med Chem Lett; 2004 May; 14(9):2253-6. PubMed ID: 15081019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel series of inhibitors of human cytomegalovirus primase.
    Cushing TD; Adrian J; Chen X; DiMaio H; Doughan B; Flygare J; Liang L; Mayorga V; Miao S; Mellon H; Peterson MG; Powers JP; Spector F; Stein C; Wright M; Xu D; Ye Q; Jaen J
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4879-83. PubMed ID: 16814545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors.
    Vendeville S; Nilsson M; de Kock H; Lin TI; Antonov D; Classon B; Ayesa S; Ivanov V; Johansson PO; Kahnberg P; Eneroth A; Wikstrom K; Vrang L; Edlund M; Lindström S; Van de Vreken W; McGowan D; Tahri A; Hu L; Lenz O; Delouvroy F; Van Dooren M; Kindermans N; Surleraux D; Wigerinck P; Rosenquist A; Samuelsson B; Simmen K; Raboisson P
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6189-93. PubMed ID: 18954982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants.
    Kazmierski WM; Hamatake R; Duan M; Wright LL; Smith GK; Jarvest RL; Ji JJ; Cooper JP; Tallant MD; Crosby RM; Creech K; Wang A; Li X; Zhang S; Zhang YK; Liu Y; Ding CZ; Zhou Y; Plattner JJ; Baker SJ; Bu W; Liu L
    J Med Chem; 2012 Apr; 55(7):3021-6. PubMed ID: 22471376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality.
    Borthwick AD; Crame AJ; Ertl PF; Exall AM; Haley TM; Hart GJ; Mason AM; Pennell AM; Singh OM; Weingarten GG; Woolven JM
    J Med Chem; 2002 Jan; 45(1):1-18. PubMed ID: 11754575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups.
    Li X; Liu Y; Zhang YK; Plattner JJ; Baker SJ; Bu W; Liu L; Zhou Y; Ding CZ; Zhang S; Kazmierski WM; Hamatake R; Duan M; Wright LL; Smith GK; Jarvest RL; Ji JJ; Cooper JP; Tallant MD; Crosby RM; Creech K; Wang A
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7351-6. PubMed ID: 23142614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.